Stellantis is relaunching the Jeep Cherokee with hopes to boost a U.S. turnaround. The Cherokee rejoins the compact and midsize vehicle markets after a three-year hiatus and will seek to compete with ...

Jeep’s lead engineer says “stay tuned” on a Grand Cherokee V8 return as Stellantis ramps up Hemi production and demand for V8 SUVs surges. Jeep Grand Cherokee lead engineer Joe Aljajawi hinted at a ...

WESTLAKE VILLAGE, CA—Welcome back, Jeep. Jeep people themselves won’t deny it: it was a bad move having no competitor in the crucial family SUV segment. The previous Cherokee disappeared a few years ...

Jeep is expanding its mission-themed “Convoy” campaign with the debut of the 2026 Gladiator Whitecap, a heritage-inspired special edition that leans into the brand’s World War II roots while keeping ...

Jeep returns the storied Cherokee name to the lineup for 2026 with a fully redesigned compact SUV featuring the brand’s first full-time all-wheel-drive hybrid powertrain as standard. Available in four ...

Compass Coffee, the beleaguered D.C.-based chain, has a new owner. Elizabeth L. Gunn, a U.S. bankruptcy judge for the District of Columbia, approved the sale Thursday to London-based giant Caffè Nero, ...

As part of Stellantis’s portfolio-wide electrification shift, Jeep started pulling V8 power from its Grand Cherokee lineup as early as 2021 with the discontinuation of the Hellcat-powered Trackhawk.

View post: Amazon Is Selling a Kershaw Pocket Knife for Over 20% Off Signature Autosports built a Jeep Wrangler Rubicon with a 707-hp supercharged Hellcat engine. Upgrades include heavy-duty cooling, ...

When someone mentions the Jeep Cherokee, car people bring up the XJ. It’s inevitable. The XJ wasn’t the first-generation Cherokee; that honor belongs to the old-school SJ, but it became the gold ...

Once upon a time, Jeep used the Grand Cherokee as a platform for some pretty surprising vehicles. At the top of the list was undoubtedly the SRT and Trackhawk variants, bringing high-performance ...

Lawmakers urge DOJ to detail its review of the $1.6B Compass-Anywhere merger, citing risks to competition and housing costs. The lawmakers say the letter comes after reports that former assistant ...

Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.